MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2337/dc15-1817

Медицинская библиотека · Diabetes care · 2016

Diabetes and the Association of Postoperative Hyperglycemia With Clinical and Economic Outcomes in Cardiac Surgery.

Greco Giampaolo, Ferket Bart S, D'Alessandro David A, Shi Wei, Horvath Keith A, Rosen Alexander, Welsh Stacey, Bagiella Emilia, Neill Alexis E, Williams Deborah L, Greenberg Ann, Browndyke Jeffrey N, Gillinov A Marc, Mayer Mary Lou, Keim-Malpass Jessica, Gupta Lopa S, Hohmann Samuel F, Gelijns Annetine C, O'Gara Patrick T, Moskowitz Alan J

СтатьяМногоцентровое исследованиеПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

The management of postoperative hyperglycemia is controversial and generally does not take into account pre-existing diabetes. We analyzed clinical and economic outcomes associated with postoperative hyperglycemia in cardiac surgery patients, stratifying by diabetes status.

RESEARCH DESIGN AND

METHODS

Multicenter cohort study in 4,316 cardiac surgery patients operated on in 2010. Glucose was measured at 6-h intervals for 48 h postoperatively. Outcomes included cost, hospital length of stay (LOS), cardiac and respiratory complications, major infections, and death. Associations between maximum glucose levels and outcomes were assessed with multivariable regression and recycled prediction analyses.

RESULTS

In patients without diabetes, increasing glucose levels were associated with a gradual worsening of outcomes. In these patients, hyperglycemia (≥180 mg/dL) was associated with an additional cost of $3,192 (95% CI 1,972 to 4,456), an additional hospital LOS of 0.8 days (0.4 to 1.3), an increase in infections of 1.6% (0.5 to 2.8), and an increase in respiratory complications of 2.6% (0.0 to 5.3). However, among patients with insulin-treated diabetes, optimal outcomes were associated with glucose levels considered to be hyperglycemic (180 to 240 mg/dL). This level of hyperglycemia was associated with cost reductions of $6,225 (-12,886 to -222), hospital LOS reductions of 1.6 days (-3.7 to 0.4), infection reductions of 4.1% (-9.1 to 0.0), and reductions in respiratory complication of 12.5% (-22.4 to -3.0). In patients with non-insulin-treated diabetes, outcomes did not differ significantly when hyperglycemia was present.

CONCLUSIONS

Glucose levels <180 mg/dL are associated with better outcomes in most patients, but worse outcomes in patients with diabetes with a history of prior insulin use. These findings support further investigation of a stratified approach to the management of patients with stress-induced postoperative hyperglycemia based on prior diabetes status.

Для цитирования: Greco Giampaolo, Ferket Bart S, D'Alessandro David A, Shi Wei, Horvath Keith A, Rosen Alexander, Welsh Stacey, Bagiella Emilia, Neill Alexis E, Williams Deborah L, Greenberg Ann, Browndyke Jeffrey N, Gillinov A Marc, Mayer Mary Lou, Keim-Malpass Jessica, Gupta Lopa S, Hohmann Samuel F, Gelijns Annetine C, O'Gara Patrick T, Moskowitz Alan J. Diabetes and the Association of Postoperative Hyperglycemia With Clinical and Economic Outcomes in Cardiac Surgery.. Diabetes care. 2016. DOI: 10.2337/dc15-1817.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.